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Summary 
Increasing evidence suggests that the nervous system is involved in allergic inflammation.  One 
of the potential regulatory molecules of the neuroimmune system is nerve growth factor (NGF). 
Recent studies from our group demonstrated the presence of a functional NGF receptor (NGFR) 
on human B lymphocytes.  Moreover, we showed that gp140  trk tyrosine kinase, which serves 
as an NGFR, was involved in transduction of early signaling events in human B lymphocytes. 
The mechanisms by which NGF initiates the signaling cascade and the link between the neu- 
roimmune systems are unknown. We have focused on the role of the cytoskeleton as a possible 
mediator for transduction of signals induced by NGF. Polymerized actin (F-actin) content was 
determined by fluorescent staining and immunoblotting with antiactin  antibody.  Addition  of 
NGF caused a time- and concentration-dependent increase in F-actin content, and maximum 
effects were noted after 1 min. These increases in F-actin content and NGF-induced thymidine 
incorporation could be blocked by incubating the cells with cytochalasin D and botulinum C2 
toxin before the addition of NGF. Incubation of human B lymphocytes with 10 nM K252a, 
an inhibitor of Trk kinase, decreased N GF-induced microfdament assembly by 75%. In immuno- 
precipitation  experiments,  addition  of NGF to B cells induced a rapid increase in the tyrosine 
phosphorylation of paxillin, one of a group of focal adhesion proteins involved in linking actin 
filaments to the plasma membrane.  Coimmunoprecipitation studies demonstrated the associa- 
tion between gp140  ~rk kinase and paxillin.  Together,  these observations suggest that actin as- 
sembly is involved in NGF signaling in human B cells, and that paxillin may be essential in 
this pathway  after phosphorylation by gp140  ~rk kinase. 
I 
ncreasing  evidence suggests  that  the nervous  system is 
involved in allergic inflammation (1). One of the potential 
regulatory molecules in the neuroimmune  axis is nerve growth 
factor (NGF) 1 (2), and recent studies from our laboratory 
have demonstrated a functional NGF receptor (NGFR) on 
human B lymphocytes (3). Moreover, we showed that Trk 
tyrosine kinase, which serves as an NGFR, was involved in 
the transduction of early signaling events in human B lym- 
phocytes (Melamed, I., C. A. Kelleher, R. A. Franklin, C. 
Brodie, J.  B.  Hempstead,  D.  Kaplan,  and E.  W.  Gelfand, 
I Abbreviations used in this paper: F, filamentous; G, globular; NBD, 7-nitro- 
benz-2-oxa-1,  3-diazole; NGF, nerve growth factor; NGFR., NGF receptor; 
PLC'/1,  phospholipase C3,1; RFI, relative fluorescence index; SH,  Src 
homology domain. 
manuscript  submitted  for  publication).  The  mechanisms 
linking the early metabolic changes induced by NGF to later 
events in these cells remain to be defined. Systems must exist 
for the transmission and regulation of such information from 
the cell surface to the nucleus, and the cytoskeleton may be 
one candidate. The cytoskeleton is a complex composed of 
microfilaments, microtubules, and intermediate filaments (4). 
Immunocytochemical  studies in lymphocytes demonstrated 
that microfilaments,  composed primarily of actin, are associated 
with the inner surface of the plasma membrane and may link 
the plasma membrane to the nucleus (5). In neuronal cells, 
a rapid redistribution of filamentous (F) actin is induced within 
a few minutes after addition of NGF.  The appearance of 
ruffling with rapid redistribution of F-actin has also been 
shown to be closely related to the subsequent outgrowth of 
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F-actin, might be one of the earliest steps in this process (7). 
The cytoskeleton plays an active  role in propagation of 
signals  in B  lymphocytes. One of the earliest  changes in 
cytoskeleton assembly in human B lymphocytes after ligand 
binding to its receptor is the conversion of  monomeric globular 
(G) actin to F-actin (8). This process is apparently linked to 
the activation of the src family of protein tyrosine kinases 
(PTKs) and precedes B cell proliferation (9).  However, the 
role of the microfilament system in transducing signals initi- 
ated by NGF in B lymphocytes and the involvement of Trk 
in microfilament assembly has not been studied. 
The propagation of intracellular signals emanating from 
a tyrosine-phosphorylated  growth factor receptor like Trk de- 
pends on interactions between the receptor and different sub- 
strates including phospholipase  Cyl (PLC3,1), phosphatidyl- 
inositol 3- kinase (PI3-kinase) (10), and SHC (11). Knowledge 
of the roles of the Src homology domains of these kinases 
in this process has expanded markedly over the past several 
years, and newer evidence implicates interactions of these do- 
mains with different cytoskeletal proteins (SH3) and signaling 
molecules (SH2) (11). One of the cytoskeletal proteins with 
a potential role in interactions with the signaling molecules 
triggered by NGFR activation is paxillin (12, 13). Paxillin 
belongs to a group of focal adhesion molecules that link actin 
filament bundles to the plasma membrane at sites of cell adhe- 
sion (13). In fibroblasts, tyrosine phosphorylation of paxillin 
increases as cells bind to fibronectin during cell spreading (14), 
concurrent with the assembly of focal adhesions (13). In PC- 
12 cells, tyrosine phosphorylation of paxillin occurs during 
neuritic outgrowth (14). In this report, we have character- 
ized NGF-induced microfilament assembly in human B lym- 
phocytes and present evidence that tyrosine phosphorylation 
of paxillin by gp140 ~rk kinase is associated  with microfila- 
ment reorganization. 
Materials  and Methods 
Cells.  Tonsillar  B cells were obtained after Ficoll-Hypaque  gra- 
dient centrifugation and E-rosette depletion as previously  described 
(15). All cells were maintained in culture in RPMI-1640 (Gibco 
Laboratories, Grand Island, NY) supplemented  with 10% FCS (Hy- 
clone Laboratories, Inc., Logan, UT),  10/zg/ml t-glutamine, 50 
U/ml penicillin, 50 ng/ml streptomycin,  and 5/zg/ml sodium pyru- 
vate (Gibco Laboratories). 
Reagents.  Anti-NGF antibody, NaF, A1C13, and cytochalasin 
D were purchased from Sigma Chemical Co. (St. Louis, MO). 
[3H]thymidine and 12SI-protein A and "t-[32p]ATP were obtained 
from  Amersham Corp.  (Arlington  Heights,  IL)  and  protein 
A-Sepharose CL4B from Pharmacia  (Uppsala, Sweden). NGF (2.5S) 
and affinity-purified  monoclonal  antiphosphotyrosine  antibody [anti- 
Tyr(P)] were purchased from Upstate Biotechnology, Inc. (Lake 
Placid, NY). Anti-Trk A antibody was generated to the unique ex- 
tracellular sequences of human Trk-A (10); antipaxillin antibody 
was prepared as described (12), and antibody to actin was kindly 
provided by Dr. J. Lessard (University of Cincinnati, Cincinnati, 
OH); K252a was obtained from Kyowa Medex (Tokyo, Japan), 
7-nitrobenz-2-oxa-1, 3-diazole (NBD)-phallacidin from Molecular 
Probes, Inc. (Eugene, OR),  and lysophosphatidylcholine from 
Avanti Polar Lipids, Inc. (Pelham, AL). Botulinum C2 toxin was 
isolated and purified as described previously (16). 
Western Blot.  Cells  (4  x  106) were incubated in the presence 
or absence of various ligands as indicated. Control cells were in- 
cubated with the appropriate exciFient  buffer control. Western  blot- 
ting was performed essentially  as described (15). Briefly,  cells were 
pelleted and the reaction stopped by lysing cells in 5  x  SDS-gel 
sample buffer, followed  immediately by boiling for 5 min. Lysates 
were frozen, thawed, centrifuged at 12,000 g for 5 min, and super- 
natants analyzed  by SDS-PAGE. The separated proteins were elec- 
trophoretically transferred to nitrocellulose or immobilon (Milli- 
pore Corp., Bedford,  MA), and the unreacted sites on nitrocellulose 
or immobilon were blocked overnight with 5% BSA (essentially 
fatty acid and globulin free, Calbiochem Novabiochem. Corp., San 
Diego, CA) in 10 mM Tris, 150 mM NaC1, and 0.01% NAN3, 
pH 8.0 (blocking  solution). The blot was incubated  with the specific 
antibody in 4 ml of blocking solution and washed twice for 10 
min in blocking solution. This was followed by a 10-min wash 
with blocking solution containing 0.5% NP-40 and twice more 
with blocking buffer. The filters were then incubated with 1 #Ci 
of 12SI-labeled protein A in 5 ml of blocking solution for 1 h and 
washed as before. The filters  were then subjected  to autoradiography. 
Immunoprecipitation.  Cells  (2  x  107) were incubated in RPMI- 
1640 for 2 min in the absence or presence of NGF at the indicated 
concentrations. Cells were subsequently washed and resuspended 
in lysis  buffer containing 20 mM Hepes (pH 7.4), 125 mM NaCI, 
1% Triton X-100, 10 mM EDTA, 2 mM EGTA, 2 mM Ya3VO4, 
50 mM sodium fluoride, 20 mM ZnC12, 10 mM sodium pyro- 
phosphate, I mM PMSF, and 5/~g/ml leupeptin, and centrifuged 
for 15 min at 12,000 g. The supernatants were used as cell lysates. 
The lysates  were incubated with 3/~g of antipaxillin antibody per 
0.5 ml of  cell  lysate  for I h on ice, and then with protein A-Sepharose 
CL4B for I h. The Sepharose  beads containing the immunoprecipi- 
tates were washed three times with washing buffer (as above ex- 
cept for PMSF and leupeptin), once with 0.5 M LiC1-0.1 M Tris 
hydrochloride  (pH 7.5) and once with 0.1 M NaCI-1 mM EDTA-2 
mM Tris hydrochloride (pH 7.5). SDS-sample buffer was added 
to the washed  immunoprecipitates,  and the samples were electropho- 
retically separated on a 10% SDS- polyacrylamide gel. 
Coimmunoprecipitation.  B cells (20  x  106) were stimulated for 
5 min with NGF (500 ng/ml). The cells were then lysed in 1% 
NP-40 lysis buffer, clarified, and then  precleared with protein 
A-Sepharose beads for 4 h at 40C. Antipaxillin antibody was added 
to the cells and allowed  to bind for 2 h at 4~  Immune complexes 
were then precipitated by adding protein A beads. The beads were 
washed three times in lysis  buffer and twice in in vitro kinase assay 
buffer (150 nM NaC1, 10 nM Hepes, 1 mM PMSF, and 2 mM 
Na3VO4), resuspended in 20/~1 of kinase buffer, and then incu- 
bated for 15 min at 30~  in the presence of 10 #Ci of 3,[32p]ATP. 
Beads were then washed twice in lysis buffer to remove free ATP 
and then boiled in 1 vol of 20 mM Tris-HC1 (pH 8.0) containing 
0.5% SDS and I mM dithiothreitol to disrupt protein-protein in- 
teractions. Secondary immunoprecipitations were performed by 
adding anti-Trk antibody and protein A beads to samples after 
diluting SDS to 0.1% with 4 vol of lysis buffer. Beads were then 
washed in lysis buffer and boiled in sample buffer, and proteins 
were resolved  by SDS-10% PAGE  and analyzed  by autoradiography. 
Antibody Blocking of NGF-induced Responses.  NGF (500 ng/ml) 
was incubated with various concentrations of anti-NGF antibody 
(1-10/.tg/ml) for 30 min at room temperature in a volume of 30 
#1. This mixture was then used to stimulate the B cells. These 
conditions were previously shown to abolish the activity of NGF 
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concentrations  of anti-BSA antibody. 
FActin Determination.  The content ofpolymerized actin (F-actin) 
in human B lymphocytes was monitored by staining fixed and per- 
meabilized cells with NBD-phallacidin by use of the methanol ex- 
traction method described by Howard and Oresajo (18). This fluores- 
cence  method  has  been  shown  to  correlate  with  biochemical 
measurements of F-actin (17).  Cells were excited  with an argon 
laser at 488 nm and emission recorded at 520 nm with band pass 
and short pass filters. Gating was done on the forward angle and 
right  angle light  scatter only to exclude  debris and cell clumps. 
A minimum of 10,000 cells was measured per condition. The results 
were quantified by fluorescence spectrophotometry. The relative 
fluorescence  index (RFI) was calculated as the ratio of the fluores- 
cence of stimulated to control cell populations by use of the ratio 
of the linearized mean fluorescence of the cell populations in ques- 
tion as provided by the data processing software. Selected  experi- 
ments were also analyzed on (Epics  Profile;  Coulter Corp.,  Hia- 
leah,  FL). 
Triton X.IO0 Extraction.  For Triton X-100 extraction (9),  2  x 
10  ~ cells were sedimented and resuspended  in Triton-PHEM buffer 
(0.75% Triton X-100, 60 mM Pipes, 25 mM Hepes, 10 mM EGTA, 
2 mM MgCI2) containing  1 mM PMSF,  20/~g/ml leupeptin,  80 
#g/ml aprotinin, and 156/zg/ml benzamidine at 4~  and allowed 
to incubate on ice for 20 min.  Next,  the insoluble  fraction was 
sedimented in a microfuge by spinning at 12,000 g for 5 rain. The 
supernatant  (soluble fraction) was removed and the pellet resus- 
pended in boiling sample buffer. 
Results 
NGF  Induces Rapid  Assembly  of FActin  in  B  Lympho- 
cytes.  Cross-linking the surface antigen receptor on B cells 
triggers a variety of membrane changes, including patching, 
capping, and endocytosis of the receptor (19). Recent studies 
from our laboratory have demonstrated the presence of func- 
tional NGF receptors on human B lymphocytes (17). To de- 
termine if microfilament assembly is involved in the early ac- 
tivation events triggered  by NGF,  we first  determined  the 
effect of NGF on microfilament assembly in human B lym- 
phocytes,  monitoring  changes  in  fluorescence  of  NBD- 
phallacidin-stained  cells, which detect F-actin.  As shown in 
Fig.  1,  A  and B,  NGF  induces  a  concentration-  and  time- 
dependent  increase in F-actin content.  F-actin assembly was 
observed in the presence of 100 ng/ml NGF, with maximum 
increases observed with 500 ng/ml (Fig.  1 A). The microfila- 
ment  assembly was  detected  within  1  min,  with  maximal 
increases detected at "~2 min after addition of NGF (Fig. 1 B). 
The  NGF-induced  conversion  of G-actin  to  F-actin  was 
also demonstrated  by immunoblotting  with  antiactin  anti- 
body (Fig. 2). Under stimulated conditions,  total actin is dis- 
tributed between the cytoplasmic Triton X-100-soluble frac- 
tion  and  the  cytoskeletal  Triton  X-100-insoluble  fraction. 
When B cells were stimulated with NGF (250 and 500 ng/ml) 
for 2 min, the amount of actin associated with the cytoskeleton 
(insoluble  fraction,  F-actin)  increased  as detected  in  immu- 
noblots  with  antiactin  antibody  (Fig.  2).  The  fluorescence 
(F-actin) distribution histograms confirmed the large increases 
in anti-F-actin  after NGF stimulation  (500 ng/ml)  (Fig.  3). 
A  2.0- 
1.11 
1.11￿84 
1.4  ￿84 
1.2- 
1.0  ,< 
I 
1.11.  NGF (ng/ml) 
1.6. 
1.4, 
1.2' 
1.o  ;  i  ~  ; 
Time (mlnutu) 
Figure  1.  F-actin  content in B cells stimulated with NGF antibody. 
B cells (101) were stimulated for 2 min with the indicated concentrations 
of NGF (A). The kinetics of the response were determined by measuring 
F-actin content in B cells  cultured with NGF (500 ng/ml) for various  periods 
of time as indicated (B).  RFI represents the relative F-actin content as- 
sayed by NBD-phallacidin staining and  was calculated as described in 
Materials and Methods. KFI data represent the mean •  SEM of six sepa- 
rate experiments conducted with different preparations of B lymphocytes. 
Figure  2.  F-actin  content in cytoskeletal  fractions of stimulated B cells. 
Antiactin immunoblots of Triton X-100-insoluble  fractions of lysates  from 
unstimulated (control) or stimulated human B cells were prepared. The 
in~bation was terminated after 2 min by pelleting the cells and solubilizing 
them in SDS sample buffer, as described in Materials and Methods. After 
electrophoresis and blotting, P-actin was detected by use of antiactin anti- 
body and 1251-protein  A beads and the mixture subjected to autoradiog- 
raphy. Densitometric analysis  indicated that in this experiment, treatment 
with NGF resulted in five-  (500 ng/ml) and twofold (250 ng/ml) increases 
in F-actin in the Triton X-100-insoluble fraction. 
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with anti-NGF antibody eliminated the increases in F-actin 
content (Fig.  4). 
Cytochalasin D and Botulinum C2 toxin Block NGF-induced 
Actin Assembly.  Since actin polymerization appears to be as- 
sociated with NGF transduction of signals in B lymphocytes, 
we determined  if there is a direct link between the cytoskeleton 
reorganization and the signaling events induced by NGF. To 
this end, we treated cells with compounds that disrupt mi- 
cro  filament assembly and monitored their effects on a late 
activation event induced by NGF in B lymphocytes, namely, 
cell proliferation. If actin polymerization was essential  for 
the transduction of NGF mitogenic signals, then prevention 
of assembly should inhibit cell proliferation induced by NGF. 
NGF-dependent cell proliferation,  assessed by [3H]thymidine 
incorporation, was blocked by cytochalasin D in a concentra- 
tion-dependent manner; 10 #M was shown to be an optimal 
inhibiting concentration (Fig. 5 A). Delaying the addition 
of cytochalasin D by I h after addition of NGF did not affect 
[3H]thymidine incorporation, thus eliminating drug toxicity 
as an explanation of these and subsequent results (Fig. 5 A). 
A 30-min pretreatment of the cells with this concentration 
of cytochalasin  D  (10  #M)  also  prevented NGF-induced 
microfilament assembly  (Fig.  5 B). 
Similar results were obtained with a second microfilament- 
disrupting agent, botulinum C2 toxin. Botulinum C2 toxin 
belongs to a new class of bacterial ADP-ribosyl transferases 
that modify nonmuscle G-actin (16). The toxin is binary in 
structure and consists  of two different components. Com- 
pound I (50,000 mol wt) possesses ADP-ribosyl transferase 
activity (16), whereas compound II is involved in the bind- 
ing of the toxin to the cell membrane. Botulinum C2 toxin 
ADP ribosylates nonmuscle  G-actin at Arg-177 (16). Moreover, 
modified G-actin binds to barbed ends of F-actin  in a cap- 
ping proteinlike manner to inhibit polymerization of actin. 
Consistent with our previous observations in human B lym- 
Figure  3.  F-actin fluorescence histogram. Human B cells were incubated 
in the absence or presence of 1/xm (CD-I) or 10/xm (CD-IO) cytochalasin 
D for 30 min and then stimulated with NGF (500 ng/ml) for 2 min. The 
cells were stained with NBD- phallacidin and analyzed by flow cytometry 
as described.  Computer traces of one (of three) representative  histograms 
are illustrated. 
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Figure  4.  Effect of anti-NGF antibody on F-actin content induced by 
NGF. NGF (500 ng/ml) was preincubated with different concentrations 
of anti-NGF antibody (solid  columns) or anti- BSA antibody (hatched  columns) 
for 30 min, and the mixture was added  to B cells (106/ml)  for 2 min. 
RFI was measured as described in Materials and Methods, and the results 
(% inhibition) represent mean +  SEM of six separate experiments. Con- 
trol RFI was 1.8  _+  0.3. 
phocytes (8), botulinum C2 toxin reduced B cell prolifera- 
tion (Fig.  6 A) and actin assembly (Fig.  6 B)  induced by 
NGF. As with cytochalasin D, delaying the addition of the 
toxin for 1 h after NGF failed to affect B cell proliferation 
(Fig. 6 A). The inhibitory effect of botulinum C2 toxin was 
dose dependent, and the maximum inhibitory effect was ob- 
tained with a dose of 2,000 ng/ml (Fig. 6 B). These results 
indicate that cytochalasin D and botulinum C2 toxin, which 
inhibit NGF-induced B cell proliferation, also block poly- 
merization of actin, suggesting a functional link between NGF 
induction of cell proliferation and cytoskeleton reorganization. 
Trk  as  a Mediator of Microfilament Assembly Induced by 
NGE  The multiple effects of NGF on B lymphocytes are 
dependent on binding of NGF to a specific  cell surface  receptor, 
where it forms a receptor-ligand complex on the cell surface 
followed by its translocation to the cytoplasm (2).  At the 
cell surface, NGF interacts with at least two components, 
gp140  trk, a member of the tyrosine kinase transmembrane 
receptor family, and p75  NGFg (20; Melamed, I., et al., manu- 
script  submitted for publication). In neuronal cells, Trk is 
required for the transduction of the neutrophic signal (21). 
In certain  cells, p75  NGFR performs an accessory role,  mod- 
ifying the ligand-binding affinity, neurotrophin specificity, 
dose responsiveness to NGF, and tyrosine kinase activity of 
Trk (22, 23). If actin polymerization induced by NGF is de- 
pendent on NGF-Trk-mediated increases in tyrosine kinase 
activity, then inhibition of the tyrosine kinase activity should 
interfere with actin assembly. We tested this possibility by 
measuring F-actin content in NGF-stimulated human B cells 
that were pretreated with K252a, a drug shown to be an in- 
hibitor of Trk (24). As indicated in Fig. 7, a 10-min preincu- 
bation with 10 nM K252a decreased the content of F-actin 
induced by 500 ng/ml NGF by 70%. As a control, anti-IgM 
antibody induced increases in F-actin  that were unaffected 
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Figure 5.  EffectofcytochalasinDonF-actincontentandBcellprolifer- 
ation induced by NGF. B cells (106/ml) were treated for 30 min with var- 
ious concentrations of cytochalasin  D and then stimulated with NGF (500 
ng/ml) (.4) for a period of 72 h, and B cell proliferation was determined 
by thymidine incorporation, or (B) for 2 min for F-actin content. Delay 
in addition of cytochalasin D for 1 h after NGF is shown in A (O-O) 
and was without effect. The data are shown as the percentage of inhibi- 
tion compared  with cells not pretreated with cytochalasin  D and represent 
the mean _+ SEM of three experiments.  Control cpm were 28,000 _+ 1,400. 
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Figure 6.  Effect  of botulinum C2 toxin on F-actin content and B cell 
proliferation induced by NGF. B cells (106/ml) were treated for 1 h with 
various concentrations of botulinum C2 toxin and then stimulated with 
NGF (500 ng/ml) for a period of 72 h. B cell proliferation  was determined 
by thymidine incorporation (A) or the cells were analyzed after 2 min 
for F-actin content (B). Delay in addition of the toxin for 1 h after NGF 
is shown in A (D-D) and was without effect. The data represent the 
percentage of maximum stimulation compared with cells not pretreated 
with botulinum C2 toxin and represent the mean _+ SEM of three ex- 
periments. Control cpm were 25,000 _+  1,400. 
by K252a (data not  shown).  This  concentration of K252a 
inhibits  Trk  kinase  phosphorylation  in  B  cells  by  80% 
(Melamed,  I., et al., manuscript submitted for publication) 
and B cell proliferation by 65% (data not shown), suggesting 
that Trk does indeed mediate the micro  filament assembly in- 
duced by NGF. 
NGF Leads to Phosphorylation of Paxillin.  The vinculin- 
binding,  focal  adhesion  protein  paxiUin  is  tyrosine  phos- 
phorylated in response to several mitogenic factors including 
bombesin, vasopressin (25), and also during cell adhesion and 
transformation  (26).  These events are also  associated with 
major rearrangements of the actin cytoskeleton. Therefore, 
tyrosine phosphorylation of paxillin may accompany the actin 
filament reorganization observed in NGF-stimulated B lym- 
phocytes. Antiphosphotyrosine immunoprecipitates, prepared 
from lysates of NGF-stimulated B lymphocytes, were assayed 
for paxillin by immunoblot analysis with an antipaxillin an- 
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tibody.  As  shown  in Fig.  8,  paxillin  protein (68  k_D) was 
phosphorylated on tyrosine residues  in human  B  lympho- 
cytes treated with  NGF  (500 ng/ml)  for 2  min. 
Paxillin Coimmunoprecipitates with Trk.  Since we identified 
gpl40 t'k as an NGFR in human B lymphocytes and showed 
that  the protein contains  tyrosine kinase activity, which is 
activated by NGF binding (Melamed, I., et al., manuscript 
submitted  for publication),  we  tested  the  hypothesis  that 
gpl40 t'k transduces microfilament assembly and the tyrosine 
phosphorylation of paxiUin. Different tyrosine-phosphorylated 
growth  factor receptors can interact with  their  substrates, 
resulting in the propagation of intraceUular signals emanating 
from these growth factor receptors (11).  First, we evaluated 
the  ability  of Trk  to  coimmunoprecipitate  with  paxillin. 
Trk was immunoprecipitated from NGF (500 ng/ml)-stim- 
ulated B lymphocytes,  and  then the products were labeled 
in an in vitro kinase reaction and boiled in 0.5% SDS buffer. 1.8 
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Figure 7.  Effect  of K252a on F-actin content induced by NGF. B ceUs 
(106/ml) were treated for 1 h with various concentrations of K252a and 
then stimulated for 2 rain for F-actin content. The data represent the mean 
_+  SEM of three  separate experiments. 
The mixture was diluted in 1% NP-40 lysis buffer (to a final 
concentration of 0.1%  SDS),  and antipaxiUin antibody and 
protein A beads were then added to detect paxiUin,  which 
had coimmunoprecipitated with Trk. Immune complexes were 
then washed, run on SDS-10%  PAGE  gels,  and subjected 
to autoradiography. The results shown in Fig. 9 illustrate that 
paxillin associates with Trk in NGF-stimulated B lymphocytes. 
Figure 9.  Coimmunoprecipitation ofpaxillin with Trk. Trk A was im- 
munoprecipitated  from control or NGF (500 ng/ml)-stimulated B cells 
(5  x  107/ml)  and subjected to in vitro kinase assays. Samples were then 
thoroughly washed and boiled in a 0.5% SDS buffer to disrupt complexes. 
Secondary  paxillln immunopredpitations were then performed after samples 
were diluted to adjust SDS to 0.1%.  Reaction products  were separated 
by 10% SDS-PAGE and analyzed by autoradiography. Molecular weight 
markers (kDa) are shown on the right. The results represent one of four 
separate experiments. 
K252a Inhibits Paxillin  Phosphorflation.  To delineate the 
role of Trk tyrosine kinase in tyrosine phosphorylation of 
paxillin, we used the inhibitor K252a and examined paxillin 
phosphorylation by NGF. Before the addition of NGF (250 
and 500 ng/ml), we preiucubated B lymphocytes with the 
inhibitor (10 riM) for 10 rain. As can be seen in Fig.  10, the 
tyrosine  phosphorylation  of paxillin  was  inhibited  after 
pretreatment with K252a. 
Figure 8.  Immunoprecipitation ofpaxillin in B cells treated with NGF 
antibody. Paxillin was immunoprecipitated from human B cells (2  x  107) 
stimulated with NGF (500 ng/ml). After the separation of immunopre- 
cipitated proteins on SDS-polyacrylamide gels, proteins were transferred 
to a nitrocellulose sheet and immunoblotted  with monoclonal antiphos- 
photyrosine antibodies. Immune complexes were detected with ml-hbeled 
protein A and autoradiography. The results represent one of three similar 
experiments. Molecular weight marker  (kDa) is shown on the right. 
Discussion 
Several pathways of signal transduction are described for con- 
verting a ligand-receptor-mediated signal received at the ex- 
tracellular surface of the plasma membrane into an intracel- 
lular signal that ultimately alters gene expression in the nucleus. 
These pathways consist of a series of chemical reactions that 
alter enzyme function. One of the central issues we approached 
in this study was to define one element of the cascade initi- 
ated by the binding of NGF to its receptor. Specifically, we 
examined the role of the microfilament system and paxillin, 
a focal adhesion protein linked to the microfilament system, 
in the propagation of signals  initiated by NGF binding to 
its receptor on human B  cells. 
The microfilament components of the cytoskeleton are com- 
posed primarily of actin, which undergoes a rapid and dra- 
matic alteration in conformation and arrangement in human 
1076  Nerve Growth Factor Triggers Microfilament Assembly in B Lymphocytes Figure 10.  K252a  inhibits paxiLlin  phosphorylation.  B lymphocyte,  were 
stimulated for 2 min with the indicated  concentrations  of NGE In the 
last two lanes, K252a (10/~M) was added 10 rain before the addition of 
NGF. PaxiLlin was  immunoprecipitated  from human B cells (2  x 
107/cells). After the separation of immunoprecipitated  proteins on an 
SDS-polyacrylamide  gel, proteins  were  transferred  to a nitrocellulose  sheet 
and immunoblotted  with monoclonal  antiphospbotyrosine  antibodies.  Im- 
mune complexes  were  detected  with 12Sl-labeled  protein A and autoradi- 
ography.  Molecular  weight  marker  (kDa)  is shown  on the right. The results 
represent one of three similar experiments. 
B lymphocytes in response to NGF stimulation. In addition 
to causing obvious membrane changes (ruffling and capping), 
these alterations in the cytoskeleton may be involved in the 
actual transduction of signals from the surface receptor, leading 
to cell activation and proliferation. Here, we provide evidence 
that  the conversion of G- to F-actin may be a prerequisite 
for NGF signaling, based on the findings that disruption of 
these processes  by cytochalasin D  and botulinum C2 toxin 
resulted in inhibition of B cell proliferation induced by NGF. 
The multiple effects of NGF on cell signaling are depen- 
dent on binding of NGF to  specific cell surface receptors. 
p75 NGFR and Trk are required for transduction of the neu- 
rotrophic signals  and proliferation events induced by NGF 
(27). The relationship between these two molecules and their 
specific contributions to NGF-induced signaling is still con- 
troversial.  Moreover, the interaction of these receptors with 
the cytoskeleton in B lymphocytes is not clear. Previous studies 
have shown that changes in cytoskeletal organization modu- 
late the distribution of NGFR (7), and that NGF is associated 
with cytoskeletal elements after its binding to receptors on 
PC-12 cells (28).  In this study, we attempted to clarify the 
role of Trk tyrosine kinase in actin assembly.  We show that 
Trk phosphorylation is an essential process in micro  filament 
assembly. By using a drug that abolishes Trk tyrosine kinase 
activity (24),  we could inhibit microfilament assembly in- 
duced by NGF. These data establish  the involvement of Trk 
kinase in the process of microfilament assembly induced by 
NGF and confirm previous data that different tyrosine ki- 
nases  are involved in microfilament assembly (9).  The Trk 
tyrosine kinase is thought to be activated by the formation 
of NGF-induced dimers or oligomers of  Trk followed by trans- 
phosphorylation on tyrosine residues (29).  Trk tyrosine ki- 
nase activity is maximal 2-10 rain after NGF binding and 
is rapidly attenuated (30).  The reduction in Trk kinase ac- 
tivity is most likely due to internalization of Trk receptors 
(31).  Microfilament reorganization may play a role in this 
internalization process. 
Since actin polymerization is linked to Src and Trk kinase 
activation, there are potential interactions between these two 
different families of kinases. Several of the proteins that form 
complexes with Trk also form stable, independent complexes 
with other signal-transducing proteins (32).  Complexes of 
multiple signaling proteins may preexist in the cytoplasm and 
rapidly translocate to the membrane, thereby localizing Trk 
to the membrane after addition of NGF to the cells. Actin 
reorganization may be important for this translocation.  A 
common feature of these signaling molecules is the presence 
of common motifs, the SH2 and SH3 regions (11). While 
the physiological role of the SH2 domains of the signaling 
molecule is slowly being unraveled, little is known about the 
function of the SH3 domains. SH3-1ike domains have been 
identified not only in SH2-containing proteins but also  in 
many molecules related to  the cytoskeleton and may serve 
as actin-binding sites (11). Recent studies indicate that SH3 
domains are responsible for the targeting of signaling mole- 
cules to specific subcellular locations, where they can interact 
with their downstream target molecules (33).  This linkage 
was recently observed by Bar-Sagi  et al.  (33),  who demon- 
strated  that  SH3  domains  of PLC3,1  by  themselves  can 
localize to  the actin cytoskeleton. They proposed that the 
SH3 domain may have a specific r~le in directing PLCyI to 
a subcellular location where it could function to regulate actin 
polymerization and interact with other substrates.  Our data, 
demonstrating that Trk kinase is involved in the propagation 
of signals in B cells, phosphorylation of downstream signaling 
molecules (Melamed, I., et al., manuscript submitted for pub- 
lication), and in microfilament assembly, support  the sug- 
gested linkage between SH2 domains of the potential  fig- 
naling molecules and SH3 domains of the cytoskeletal proteins. 
In PC-12 cells, the redistribution of F-actin occurs within 
10 min of NGF addition, marking the first step in the for- 
mation of focal contacts, the sites that colocalize with vin- 
culin  by  immunofluorescence staining  (13).  Paxillin  is  a 
vinculin-binding protein and was originally identified as a 
component of focal adhesion contact where the actin cyto- 
skeleton is  linked  to  the extracellular matrix  via  integrin 
receptors (13).  Interest in paxiUin  as a cytoskeletal protein 
with an important role in NGF  signaling is based on the 
following:  (a) paxiUin  is one of the SH3-binding proteins 
(34),  and (b) paxillin is also a major substrate of pp60 s'c in 
v-Src-transformed cells,  as well as a major tyrosine kinase 
substrate in developing tissue (35).  Localization of Src via 
its SH3 domain to focal adhesions through paxillin may be 
1077  Melamed  et al. one mechanism for linking tyrosine phosphorylation and focal 
adhesion formation (36, 37). We demonstrated that paxillin 
is involved in the signaling initiated by NGF binding to human 
B lymphocytes. NGF leads to tyrosine phosphorylation of 
paxillin, and paxillin can coimmunoprecipitate with Trk, sug- 
gesting that gp140 trk can interact with the cytoskeletal pro- 
teins and the microfilament system through its activation of 
paxillin. Moreover,  we have shown that Trk kinase has an 
active role in paxiUin phosphorylation. By using a Trk ki- 
nase inhibitor, we could delineate the role of Trk in microfila- 
ment assembly and B cell proliferation. In addition, we have 
shown an association between Trk and paxiUin,  indicating 
an important link between the Trk kinase and the micro  fila- 
ment system through the association  with paxillin. Similar 
associations have been shown in the past between a different 
focal adhesion molecule, FAK, and a different tyrosine ki- 
nase family, the Src family of kinases (38). Such interactions 
between different cytoskeletal proteins and specific tyrosine 
kinases  may determine how different growth  factors  and 
ligands, sharing the same signaling molecules,  can achieve 
specificity in the signaling cascade. 
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